A 5-Year Retrospective Analysis of Antibiotic Utilisation Pattern by AWaRe Classification in Qatar
,
Abstract
Background: To analyse the trend and pattern of antibiotic consumption rates over a period of five years in a secondary care hospital in Qatar. Consumption of antibiotics is a crucial factor in the evaluation of antibiotic usage.
Methods: To measure and compare a five-year antibiotic consumption trend in inpatient department wards using Defined Daily Dose (DDD) per 100 bed days (DDD/100-BD). Antibiotics dispensed between January 2018 and December 2022 were evaluated. Data collection was done using Microsoft Excel. The analysis was done using the World Health Organization (WHO) AWaRe classification of antibiotics.
Results: The analysis showed that antibiotic consumption significantly increased from 2018 (4.11 DBD) to 2020 (15.55 DBD) and then sustained thereafter. Widely used antibiotic belongs to the third generation cephalosporins which is under Watch class of antibiotics. Ceftriaxone, cefuroxime, and amoxicillin clavulanate were the most consumed antibiotics in the hospital throughout the study period at 53.92 DBD, 32.22 DBD and 21.65 DBD respectively.
Conclusion: Establish benchmarking at the facility level. We observed the use of ceftriaxone is more as surgical prophylaxis, which is a Watch group of antibiotics, however there is zero use of restricted antimicrobials. Increase in parenteral fluroquinolone especially levofloxacin needs monitoring, which is not included in WHO essential list of medication. There is a scope to measure the appropriateness of antibiotics, as well as the duration of therapy. The goal of WHO Target ≥60% of total antibiotic consumption being Access group antibiotics can be used as an index to analyse the comparative use Watch and Access group of antibiotics.
2. Amaha ND, Weldemariam DG, Berhe YH. Antibiotic consumption study in two hospitals in Asmara from 2014 to 2018 using WHO’s defined daily dose (DDD) methodology. PLOS One 2020;15(7):e0233275.
3. Balkhy HH, Assiri AM, Al Mousa H, et al. The strategic plan for combating antimicrobial resistance in Gulf Cooperation Council States. J Infect Public Health. 2016;9(4):375-85.
4. Antimicrobial Resistance (AMR). World Bank. Available from: https://www.worldbank.org/en/topic/health/brief/antimicrobial-resistance-amr
5. Butt AA, Navasero CS, Thomas B, et al. Antibiotic prescription patterns for upper respiratory tract infections in the outpatient Qatari population in the private sector. Int J Infect Dis. 2017;55:20–3.
6. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and Therapeutics. 2015;40(4):277.
7. Mboya EA, Sanga LA, Ngocho JS. Irrational use of antibiotics in the Moshi Municipality Northern Tanzania: a cross sectional study. Pan Afr Med J. 2018; 31: 165.
8. Devi S. AMR in the Middle East:a perfect storm. Lancet. 2019;394(10206):1311–2.
9. Sid Ahmed MA, Abdel Hadi H, Abu Jarir S, et al. Impact of an antimicrobial stewardship programme on antimicrobial utilization and the prevalence of MDR Pseudomonas aeruginosa in an acute care hospital in Qatar. JAC-Antimicrobial Resistance. 2020;2(3):dlaa050.
10. World Health Organization: Antimicrobial resistance global report on surveillance: 2014 summary. World Health Organization, 2014.
11. CDC. Antibiotic Use in the United States, 2017: Progress and Opportunities. Atlanta, GA: US Department of Health and Human Services, CDC; 2017
12. Holloway K, Van Dijk L, The world medicines situation 2011 Rational use of medicines. Geneva: WHO, 2011.
13. Ardila CM, Granada MI, Guzmán IC. Antibiotic resistance of subgingival species in chronic periodontitis patients. J Periodontal Res. 2010;45(4):557-63.
14. Barlam TF, Cosgrove SE, Abbo LM, et al. Executive summary: implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):1197-202.
15. Sexton DJ, Moehring RW. Implementation of Antimicrobial Stewardship Programs in Small Community Hospitals: Recognizing the Barriers and Meeting the Challenge. Clin Infect Dis. 2017;65(4):697–8.
16. Bansal D, Jaffrey S, Al-Emadi NA, et al. A new One Health Framework in Qatar for future emerging and re-emerging zoonotic diseases preparedness and response. One Health. 2023;16:100487.
17. Global antimicrobial resistance and use surveillance system (GLASS) report 2022. Geneva: World Health Organization; 2022.
18. WHO. WHO releases the 2019 AWaRe Classification Antibiotics. www.who.int. 2019. Available from: https://www.who.int/news/item/01-10-2019-who-releases-the-2019-aware-classification-antibiotics.
19. WHOCC - WHO Collaborating Centre. www.whocc.no. [cited 2023 Apr 1]. Available from: https://www.whocc.no/atc_ddd_methodology/who_collaborating_centre.
20. Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51-77.
21. Ahmed MS, Hassan AA, Jarir SA, et al. Emergence of multidrug-and pandrug-resistant Pseudomonas aeruginosa from five hospitals in Qatar. Infect Prev Pract. 2019;1(3-4):100027.
22. Lee H, Jung D, Yeom JS, et al. Evaluation of ceftriaxone utilization at multicenter study. Korean J Intern Med. 2009;24(4):374.
23. Pinto Pereira LM, Phillips M, Ramlal H, Teemul K, Prabhakar P. Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy. BMC Infect Dis. 2004;4:1-7.
24. Mazuski JE, Tessier JM, May AK, et al. The surgical infection society revised guidelines on the management of intra-abdominal infection. Surg Infect. 2017;18(1):1-76.
25. World Health Organization Model List of Essential Medicines, 21st List, 2019. Geneva: World Health Organization; 2019.
26. Nasr ZG, Jibril F, Elmekaty E, Sonallah H, Chahine EB, AlNajjar A. Assessment of antimicrobial stewardship programs within governmental hospitals in Qatar: a SWOC analysis. Int J Pharm Pract. 2021;29(1):70-7.
27. Nasr Z, Babiker A, Elbasheer M, Osman A, Elazzazy S, Wilby KJ. Practice implications of an antimicrobial stewardship intervention in a tertiary care teaching hospital, Qatar. East Mediterr Health J. 2019;25(3):172–80.
28. Ponto JA. ASHP statement on the pharmacist’s role in antimicrobial stewardship and infection prevention and control. Am J Health Syst Pharm. 2010;67(7):575-7.
| Files | ||
| Issue | Vol 11, No 2 (Spring 2023) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/jpc.v11i2.13361 | |
| Keywords | ||
| Antibiotic Consumption; Defined Daily Dose; World Health Organization | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
